Arrayjet has expanded its range non-contact technologies with the launch of a custom microarray services offering, to flexibly meet the needs of a broader selection of customers.
Arrayjet entered the microarray market in 2005 when it launched the first of its suite of four microarrayers based on the company's non-contact technology and has since sold more than forty instruments worldwide to organisations such as The Roslin Institute, The Medical Research Council of Great Britain, EMBL, Cornell University, Millipore, Novartis and Caltech.
According to Arrayjet, it has previously been focused on delivering its core microarray printing products based on its own inkjet technology, but throughout this time has had enquiries from researchers wanting to access its printing technology and microarray development expertise on a usage basis.
The company's custom microarray services address this demand, while it continues to manufacture and sell its standard instruments.
It will also offer a hybrid business model, in which customers can initially work with Arrayjet on assay development and custom microarray printing, before electing to take control of production in their own facility when they are ready.
Arrayjet will then transfer the entire production solution as part of the service.
The company's products include its first product, the Aj100 Marathon Inkjet Microarrayer, as well as the Super-Marathon (Aj120) and the Sprint.
Later models included the Ultra-Marathon and Ultra-Marathon II Inkjet Microarrayers, both of which are capable of printing microarrays on up to 1,000 slides in a single, fully automated print run.
